Edwards Lifesciences Corp·4

Feb 5, 6:21 PM ET

VALERIANI NICHOLAS J 4

4 · Edwards Lifesciences Corp · Filed Feb 5, 2021

Insider Transaction Report

Form 4
Period: 2021-02-04
Transactions
  • Exercise/Conversion

    Common Stock

    2021-02-04$20.76/sh+22,608$469,30467,896 total
  • Exercise/Conversion

    Director Stock Option (Right to Acquire)

    2021-02-0422,6080 total
    Exercise: $20.76From: 2015-11-13Exp: 2021-11-12Common Stock (22,608 underlying)
  • Sale

    Common Stock

    2021-02-04$85.21/sh8,200$698,75259,696 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $85.1900 to $85.2800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    doc4.xmlPrimary